Affiliation:
1. Scientific Сentre for Family Health and Human Reproduction Problems
Abstract
Background. The incidence of diseases associated with impaired transport and oxidation of fatty acids is from 1:5,000 to 1:9,000 newborns. High morbidity, risk of death in the absence of timely correction, non-specificity of clinical manifestations define the importance of their timely laboratory diagnosis based on the determination of free carnitine and acylcarnitines in the blood. Reference values for free carnitine and acylcarnitines vary in different populations. The aim. To determine the reference intervals of free carnitine and acylcarnitines in newborns of the Irkutsk region and to compare them with similar reference intervals in newborns in other countries. Methods. The analysis of 229 samples of drу blood spots of healthy newborn children of the Irkutsk region aged from 0 to 7 days was carried out. Analysis of acylcarnitine concentrations was performed using high performance liquid chromatography with tandem mass spectrometry. Results. 2.5 and 97.5 percentiles (µmol/l) were calculateed for 13 acylcarnitines: C0 – [8.78; 38.08]; C2 – [3.55; 19.09]; C3 – [0.33; 1.96]; C4 – [0.08; 0.51]; C5 – [0.06; 0.44]; C5DC – [0.03; 0.17]; C6 – [0.01; 0.07]; C8 – [0.01; 0.07]; C10 – [0.02; 0.07]; C12 – [0.04; 0.51]; C14 – [0.07; 0.24]; C16 – [0.58; 3.25]; C18 – [0.35; 1.16]. Conclusion. Differences in acylcarnitine reference intervals were found: compared with other countries, the concentrations of reference intervals for C0, C2, C3, C5DC, C8, C10, C14, C16 and C18 were lower in our study, reference intervals for C5 and C12 were higher in our country.
Subject
General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology
Reference32 articles.
1. Nikolayeva E. A, Mamedov I. S. Hereditary fatty acid metabolic defects in children: diagnosis and treatment. Rossiyskiy vestnik perinatologii i pediatrii. 2009; 54 (2): 51-65. (In Russ.).
2. Nikolayeva E. A., Shulyakova I. V., Tsygankova P. G., Baidakova G. V., Zakharova E. Yu., Belousova E. D. Symptomatic epilepsy as a manifestation of very long chain acyl-coa dehydrogenase deficiency. Rossiyskiy vestnik perinatologii i pediatrii. 2008; 53 (3): 87-91. (In Russ.).
3. Ruiz-Sala P., Peña-Quintana L. Biochemical markers for the diagnosis of mitochondrial fatty acid oxidation diseases. J Clin Med. 2021; 10 (21): 4855. doi: 10.3390/jcm10214855
4. La Marca G. Mass spectrometry in clinical chemistry: the case of newborn screening. J Pharm Biomed Anal. 2014; 101: 174-182. doi: 10.1016/j.jpba.2014.03.047
5. Knottnerus S. J., Bleeker J. C., Wüst R. C., Ferdinandusse S., I. Jlst L., Wijburg F. A., et al. Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle. Rev Endocr Metab Disord. 2018; 19 (1): 93-106. doi: 10.1007/s11154-018-9448-1
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献